ACTIVE

ODYSSEA PHARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result35,9 M €+220,6 %over 1 year

Revenue76,2 M €+75,5 %over 1 year

Equity76,4 M €+88,4 %over 1 year

Workforce62,4 ETP+5,8 %over 1 year

Identity

Source · BCE/KBO

ODYSSEA PHARMA is a Private limited company incorporated in 2007. Its registered office is in Grâce-Hollogne. It employs on average 62,4 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0892.121.272
Incorporation: 18/09/2007
Legal form: Private limited company
Registered office: Rue du Travail 16
4460 Grâce-Hollogne · WallonieSee on map
Contributed capital: 90 146 335,82 €
Latest accounts: 31/12/2025
Average workforce: 62,4 ETP

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 17 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	76,2 M €	+75.5%	43,4 M €	+22.9%	35,3 M €	-15.7%	41,9 M €	-18.6%	51,5 M €
EBITDA	42,9 M €	+220%	13,4 M €	+275%	3,6 M €	-68.6%	11,4 M €	-40.5%	19,2 M €
Operating result	40 M €	+269%	10,8 M €	+3799%	277,8 k €	-93.9%	4,5 M €	+303%	1,1 M €
Net result	35,9 M €	+221%	11,2 M €	+428%	-3,4 M €	-121%	16 M €	+39.6%	11,5 M €
Balance sheet
Equity	76,4 M €	+88.4%	40,5 M €	+38.1%	29,4 M €	-10.4%	32,8 M €	+95.3%	16,8 M €
Total assets	91 M €	+79.6%	50,7 M €	-3.5%	52,5 M €	+30.8%	40,1 M €	-2.6%	41,2 M €
Cash	0 €		0 €	-100%	120,8 k €	-89.6%	1,2 M €	-72.0%	4,1 M €
Debts	14,6 M €	+44.4%	10,1 M €	-56.2%	23,1 M €	+215%	7,3 M €	-69.9%	24,4 M €
Other
Workforce	62,4 ETP	+5.8%	59,0 ETP	-4.2%	61,6 ETP	-8.3%	67,2 ETP	+3.1%	65,2 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 M€ and 500 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 30 ended

Active mandates

David Brésart

Director · since 18 juillet 2025

Active

Maurice Mulders

Director · since 18 juillet 2016

Active

Ended mandates

Elisabeth Celine Colette Kerstens

Director · since 01 novembre 2022 · until 01 avril 2024

Ended

Elisabeth Celine Colette Kerstens

Director · since 01 novembre 2022 · until 12 avril 2024

Ended

Elisabeth Celine Colette Kerstens

Director · since 01 novembre 2020 · until 01 avril 2024

Ended

Elisabeth Celine Colette Kerstens

Director · since 01 novembre 2020

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	03/07/2026	23/07/2025	18/07/2024	10/07/2024	06/07/2022	26/07/2021
General meeting	30/06/2026	18/07/2025	28/06/2024	20/06/2024	30/06/2022	01/07/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/06/2026	03/07/2026	French	PDF
Full model	31/12/2024	18/07/2025	23/07/2025	French	PDF
Full model	31/12/2023	28/06/2024	18/07/2024	French	PDF
Full modelCorrection	31/12/2022	20/06/2024	10/07/2024	French	PDF
Full model	31/12/2022	20/07/2023	09/08/2023	French	PDF
Full model	31/12/2021	30/06/2022	06/07/2022	French	PDF
Full model	31/12/2020	01/07/2021	26/07/2021	French	PDF
Full model	31/12/2019	19/06/2020	31/07/2020	French	PDF
Full model	31/12/2018	28/06/2019	22/07/2019	French	PDF
Full model	31/12/2017	29/06/2018	27/07/2018	French	PDF
Full model	31/12/2016	27/09/2017	12/10/2017	French	PDF
Full model	31/12/2015	13/06/2016	05/07/2016	French	PDF
Full model	31/12/2014	26/06/2015	24/07/2015	French	PDF
Full model	31/12/2013	06/06/2014	28/08/2014	French	PDF
Abridged model	31/12/2012	07/06/2013	28/06/2013	French	PDF
Abridged modelCorrection	31/12/2011	01/06/2012	05/12/2012	French	PDF
Abridged model	31/12/2011	01/06/2012	31/07/2012	French	PDF
Abridged model	31/12/2010	03/06/2011	25/07/2011	French	PDF
Abridged model	31/12/2009	04/06/2010	02/07/2010	French	PDF
Abridged model	31/12/2008	05/06/2009	10/06/2009	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 M€ and 500 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 30 ended

Active mandates

David Brésart

Director · since 18 juillet 2025

Active

Maurice Mulders

Director · since 18 juillet 2016

Active

Ended mandates

Elisabeth Celine Colette Kerstens

Director · since 01 novembre 2022 · until 01 avril 2024

Ended

Elisabeth Celine Colette Kerstens

Director · since 01 novembre 2022 · until 12 avril 2024

Ended

Elisabeth Celine Colette Kerstens

Director · since 01 novembre 2020 · until 01 avril 2024

Ended

Elisabeth Celine Colette Kerstens

Director · since 01 novembre 2020

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates04/09/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates17/12/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates30/07/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates30/01/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates05/12/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DIVERS - OBJET - DEMISSIONS, NOMINATIONS
PDF
Mandates24/05/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates16/11/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates12/02/2021
DEMISSIONS, NOMINATIONS - MODIFICATION FORME JURIDIQUE
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202535,9 M €↑
18/07/2025
nominationDavid Brésart — administrateur
2024
Annual accounts 202411,2 M €↑
04/10/2024
nominationEY Réviseurs d'Entreprises — commissaire
04/10/2024
nominationThomas Meurice — représentant permanent
01/04/2024
nominationKai Welzel — délégué à la gestion journalière
2023
Annual accounts 2023-3,4 M €↓
02/12/2023
autreLionel Rosoux
2022
Annual accounts 202216 M €↑
30/06/2022
reconductionSRL PwC Réviseurs d'Entreprises — commissaire
30/06/2022
nominationMélanie Adorante — représentant permanent
2021
Annual accounts 202111,5 M €↑
2020
Annual accounts 20205,2 M €↑
2019
Annual accounts 2019-7,9 M €↑
2018
Annual accounts 2018-13,9 M €↓
2017
Annual accounts 20171,3 M €↑
2016
Annual accounts 2016-36,9 M €↓
2015
Annual accounts 2015-18,9 M €↓
2013
Annual accounts 2013-5,1 M €↓
2012
Annual accounts 2012-4,7 M €↓
2011
Annual accounts 2011-2,7 M €↓
2010
Annual accounts 20105 k €↓
2009
Annual accounts 2009410,6 k €↑
2008
Annual accounts 2008-636,8 k €
18/09/2007
IncorporationPrivate limited company

ODYSSEA PHARMA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline